Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00302692Phase 2Unknown
Phase 2, randomised, open-label trial of esmolol and metoprolol in multiple trauma (2 arms), sponsored by UT Southwestern Medical Center. Primary endpoints: Mortality and Cardiovascular Morbidity. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00302692.